drug development

FDA’s Vinay Prasad Resigns: Controversy & Criticism Explained

by

Archyde The Food and Drug Administration experienced a period of significant internal debate and external scrutiny under the leadership of Dr. Vinay Prasad, who recently announced his departure next month. His… You can read the full story here: FDA’s Vinay Prasad Resigns: Controversy & Criticism Explained. Source link

PCSK9 Base Editing for Hypercholesterolemia: Phase 1 Trial Results

by

Archyde A new approach to gene editing, known as base editing, has demonstrated initial success in lowering cholesterol levels in individuals with familial hypercholesterolemia, a common genetic condition. The findings, published… You can read the full story here: PCSK9 Base Editing for Hypercholesterolemia: Phase 1 Trial Results. Source link

Understanding the Role of TREM2 in Alzheimer’s Disease: Insights and Implications

by

Archyde Recent advances in Alzheimer’s disease research have spotlighted the TREM2 agonistic antibody AL002, which has shown promise in early-stage clinical trials. This phase 2 randomized trial aimed to assess the… You can read the full story here: Understanding the Role of TREM2 in Alzheimer’s Disease: Insights and Implications. Source link

NICE recommends new innovative migraine pills helping thousands

by

Image: ©fizkes | iStock NICE has recommended new migraine pills, giving thousands faster relief from attacks and transforming treatment Thousands of people in England are experiencing renewed relief from migraines thanks to groundbreaking pills recommended by NICE. These newly approved medications target a key migraine-triggering protein, offering a highly effective and simple solution for patients … Read more

Earlier SGLT-2 inhibitors for type 2 diabetes could cut deaths, says NICE

by

image: ©Halfpoint | iStock New guidance from NICE recommends earlier use of SGLT-2 inhibitors and personalised treatment for people with type 2 diabetes, potentially reducing deaths and protecting heart and kidney health while saving the NHS millions According to NICE analysis, the updated recommendations could prevent thousands of deaths over the next few years, improve … Read more

RNA-targeting small molecules: a new frontier of drug discovery

by

Historically, drug discovery has centred around proteins but as targets become increasing saturated, novel RNA-targeting drugs indicate potential in rare diseases and oncology. Photo by Christoph Burgstedt/iStock / Getty Images Plus via Getty Images. While small molecules have long been the cornerstone of the pharmaceutical industry, there is increasingly a demand for… Source link

AI Startup Expert Intelligence Raises $4.7 Million to Automate Regulated Laboratory Data Analysis with AI

by

Archyde Artificial Intelligence Startup Expert intelligence Secures $4.7 Million in Seed Funding San Francisco, california – Expert Intelligence, a pioneering start-up focused on Artificial Intelligence solutions for regulated laboratory environments, has… You can read the full story here: AI Startup Expert Intelligence Raises $4.7 Million to Automate Regulated Laboratory Data Analysis with AI. Source link

Challenges in applying the EU AI act research exemptions to contemporary AI research

by

Kurzweil, R. The Singularity Is Nearer: When We Merge with AI. (Viking, New York, 2024). Acemoglu, D. & Johnson, S. Power and Progress: Our Thousand-Year Struggle Over Technology and Prosperity (Public Affairs, 2023). Stanford Institute for Human-Centered AI. AI Index Report 2024. (Stanford University Stanford, CA, 2024) https://aiindex.stanford.edu/report/. European Commission. European AI Research and Innovation. … Read more